Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$125.00K$125.00Kderived±0.0% vs Q4 2019 Net Income-$3.01M-$3.01MderivedN/M vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$4,793,860N/M Operating Cash Flowderived-$3,731,620N/M Free Cash Flowderived-$3,736,794N/M Margins · derivedOperating margin-3835.1%−37.0 pt vs Q4 2019
Net margin-2409.7%+72.5 pt vs Q4 2019
ended Dec 31, 2020 · filed Mar 19, 2021 · 78 d after period end